l carnitine and cancer patients The system metabolic plasticity A glutathione-responsive L-carnitine-modified camptothecin oral

SinghRKHakaASAsmalABarbosa-LorenziVCGroshevaIChinHFet alTLR4 (toll-like receptor 4)-dependent signaling drives extracellular catabolism of LDL (low-density lipoprotein) aggregates

Heart and vascular health are essential for overall well-being

& Raines, C

Three structural features a lid domain, a glycine-rich loop, and an alanine-rich loop define the active site of hGS (Figure 4B)

2286-C CircZBTB46 ALLEVIATES NON-ALCOHOLIC FATTY LIVER DISEASE BY TARGETING MIR-326/FGF1/AMPK AXIS Qingmin Zeng 1 , Chang-Hai Liu 1 , Wei Jiang 1 , Dongbo Wu 1 and Hong Tang 2 , (1)West China Hospital, Sichuan University, (2)West China Hospital of Sichuan University Background: Non-alcoholic fatty liver disease (NAFLD) is currently the most prevalent cause of chronic liver diseases worldwide